- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rohto Pharmaceutical (4527)
Rohto Pharmaceutical stock price live, this page displays TYO 4527 stock exchange data. View the 4527 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Rohto Pharmaceutical real time stock price chart below.
What Is the Rohto Pharmaceutical Stock Price Today?
The Rohto Pharmaceutical stock price today is 2,485.5.
What Is the Stock Symbol for Rohto Pharmaceutical?
The stock symbol for Rohto Pharmaceutical is ""4527.""
What Stock Exchange Does Rohto Pharmaceutical Trade On?
Rohto Pharmaceutical is listed and trades on the Tokyo stock exchange.
Is Rohto Pharmaceutical a Good Stock to Buy?
Determining whether Rohto Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4527 quote. (ISIN: JP3982400008)
What Is the Rohto Pharmaceutical Stock Price Today?
The Rohto Pharmaceutical stock price today is 2,485.5.
What Is the Stock Symbol for Rohto Pharmaceutical?
The stock symbol for Rohto Pharmaceutical is ""4527.""
What Stock Exchange Does Rohto Pharmaceutical Trade On?
Rohto Pharmaceutical is listed and trades on the Tokyo stock exchange.
Is Rohto Pharmaceutical a Good Stock to Buy?
Determining whether Rohto Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4527 quote. (ISIN: JP3982400008)
Tokyo
Currency in JPY
2,485.5
+11.5(+0.46%)
Delayed Data·
Fair Value
An estimate of a Rohto Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,457.0
2,494.5
52 wk Range
1,964.5
3,688.0
4527 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4527 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Rohto Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,457.02,494.5
52 wk Range
1,964.53,688.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4527 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Rohto Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2,606.7
Upside
+4.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 5 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Rohto Pharmaceutical Company Profile
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
Compare 4527 to Peers and Sector
Metrics to compare | 4527 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4527PeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.3x | 26.5x | 12.1x | |
PEG Ratio | 1.24 | −0.89 | 0.03 | |
Price/Book | 2.1x | 1.5x | 1.5x | |
Price / LTM Sales | 1.7x | 1.2x | 0.9x | |
Upside (Analyst Target) | 9.1% | −1.0% | 16.2% | |
Fair Value Upside | Unlock | 16.1% | 10.6% | Unlock |
Analyst Ratings
5 Buy
3 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2,606.7
(+4.87% Upside)
Earnings
Latest Release
Aug 06, 2025
EPS / Forecast
52.09 / --
Revenue / Forecast
81.96B / 78.72B
People Also Watch
FAQ
What Stock Exchange Does Rohto Pharmaceutical Trade On?
Rohto Pharmaceutical is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Rohto Pharmaceutical?
The stock symbol for Rohto Pharmaceutical is "4527."
What Is the Rohto Pharmaceutical Market Cap?
As of today, Rohto Pharmaceutical market cap is 561.07B.
What Is Rohto Pharmaceutical's Earnings Per Share (TTM)?
The Rohto Pharmaceutical EPS (TTM) is 150.90.
When Is the Next Rohto Pharmaceutical Earnings Date?
Rohto Pharmaceutical will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is 4527 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Rohto Pharmaceutical Stock Split?
Rohto Pharmaceutical has split 2 times.
How Many Employees Does Rohto Pharmaceutical Have?
Rohto Pharmaceutical has 9144 employees.
What is the current trading status of Rohto Pharmaceutical (4527)?
As of 19 Aug 2025, Rohto Pharmaceutical (4527) is trading at a price of 2,485.50, with a previous close of 2,474.00. The stock has fluctuated within a day range of 2,457.00 to 2,494.50, while its 52-week range spans from 1,964.50 to 3,688.00.
What Is Rohto Pharmaceutical (4527) Price Target According to Analysts?
The average 12-month price target for Rohto Pharmaceutical is JPY2606.66667, with a high estimate of JPY3700 and a low estimate of JPY1750. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +4.87% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.